Lisata Therapeutics logo

Lisata Therapeutics Share Price (NASDAQ: LSTA)

$2.32

-0.03

(-1.28%)

Last updated on

Check the interactive Lisata Therapeutics Stock chart to analyse performance

Lisata Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.31
    Today's High:$2.40

    Day's Volatility :3.75%

  • 52 Weeks Low:$1.87
    52 Weeks High:$4.20

    52 Weeks Volatility :55.48%

Lisata Therapeutics Stock Returns

PeriodLisata Therapeutics IncIndex (Russel 2000)
3 Months
-15.33%
0.0%
6 Months
7.91%
0.0%
1 Year
-16.85%
0.0%
3 Years
-62.88%
-4.7%

Lisata Therapeutics Inc Key Stats

Check Lisata Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.35
Open
$2.31
Today's High
$2.4
Today's Low
$2.31
Market Capitalization
$21.9M
Today's Volume
$32.8K
52 Week High
$4.2
52 Week Low
$1.87
Revenue TTM
$1.1M
EBITDA
$-20.8M
Earnings Per Share (EPS)
$-2.23
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-64.4%

Stock Returns calculator for Lisata Therapeutics Stock including INR - Dollar returns

The Lisata Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lisata Therapeutics investment value today

Current value as on today

₹86,974

Returns

₹13,026

(-13.03%)

Returns from Lisata Therapeutics Stock

₹18,310 (-18.31%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Lisata Therapeutics Stock

150%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Lisata Therapeutics Stock from India on INDmoney has increased by 150% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lisata Therapeutics Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    2.95%

  • BML Capital Management LLC

    2.43%

  • Renaissance Technologies Corp

    1.19%

  • Geode Capital Management, LLC

    0.70%

  • BlackRock Inc

    0.64%

  • Dimensional Fund Advisors, Inc.

    0.30%

Analyst Recommendation on Lisata Therapeutics Stock

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Lisata Therapeutics(by analysts ranked 0 to 5 stars)

Lisata Therapeutics Share Price Target

What analysts predicted

Upside of 790.81%

Target:

$20.67

Current:

$2.32

Lisata Therapeutics share price target is $20.67, a slight Upside of 790.81% compared to current price of $2.32 as per analysts' prediction.

Lisata Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, LSTA stock has moved down by -10.4%
  • LSTA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 88.2%
  • Price to Sales

    ForLSTA every $1 of sales, investors are willing to pay $18.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Lisata Therapeutics Technicals Summary

Sell

Neutral

Buy

Lisata Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lisata Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lisata Therapeutics Inc logo
-6.83%
7.91%
-16.85%
-62.88%
-62.88%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Lisata Therapeutics Inc

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Organization
Lisata Therapeutics
Employees
26
CEO
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
Industry
Miscellaneous

Key Management of Lisata Therapeutics Inc

NameTitle
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
President, CEO & Director
Mr. James Nisco
Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer
Dr. Kristen K. Buck M.D.
Executive VP of R&D and Chief Medical Officer
Mr. Tariq Imam
Senior VP of Business Development & Operations and General Counsel
Mr. Gregory S. Berkin
Chief Information & Data Protection Officer
Mr. John D. Menditto
Vice President of Investor Relations & Corporate Communications
Dr. William K. Sietsema Ph.D.
Vice President of Global Regulatory Affairs

Important FAQs about investing in LSTA Stock from India :

What is Lisata Therapeutics share price today?

Lisata Therapeutics share price today is $2.32 as on at the close of the market. Lisata Therapeutics share today touched a day high of $2.40 and a low of $2.31.

What is the 52 week high and 52 week low for Lisata Therapeutics share?

Lisata Therapeutics share touched a 52 week high of $4.20 and a 52 week low of $1.87. Lisata Therapeutics stock price today i.e. is closed at $2.32, lower by 44.76% versus the 52 week high.

How to invest in Lisata Therapeutics Stock (LSTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lisata Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lisata Therapeutics Shares that will get you 0.6466 shares as per Lisata Therapeutics share price of $2.32 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lisata Therapeutics Stock (LSTA) from India?

Indian investors can start investing in Lisata Therapeutics (LSTA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Lisata Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Lisata Therapeutics share’s latest price of $2.32 as on August 30, 2025 at 1:29 am IST, you will get 4.3103 shares of Lisata Therapeutics. Learn more about fractional shares .

What are the returns that Lisata Therapeutics has given to Indian investors in the last 5 years?

Lisata Therapeutics stock has given -62.88% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?